Growth Metrics

Artivion (AORT) Return on Capital Employed (2011 - 2026)

Artivion posted quarterly Return on Capital Employed of 4.72% for Q1 2026, up 260.0% year-on-year from 1.31% in Q1 2025, and up 7.77% on a QoQ basis from 4.38% in Q4 2025.

Artivion (AORT) has 16 years of Return on Capital Employed data on file, last reported at 4.72% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 260.0% year-over-year to 4.72%; the trailing twelve-month figure through Mar 2026 stood at 4.72% (up 260.0% YoY), and the FY2025 full-year result was 4.59%, down 78.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 4.72%, up from 4.38% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 6.12% in Q3 2024 and bottomed at 1.03% in Q3 2022.
  • The 5-year median for Return on Capital Employed is 2.13% (2025), against an average of 2.51%.
  • The widest annual swing landed in 2022, when Return on Capital Employed plunged 360 bps; it then soared 519 bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.88% in 2022, then slipped by 10 bps to 0.79% in 2023, then soared by 574 bps to 5.33% in 2024, then dropped by 18 bps to 4.38% in 2025, then climbed by 8 bps to 4.72% in 2026.
  • The last three Return on Capital Employed figures came in at 4.72% (Q1 2026), 4.38% (Q4 2025), and 3.38% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.61%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.24%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 7.36%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 7.62%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.30%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 11.57%
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn 4.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.72%
Dec 31, 2025 4.38%
Sep 30, 2025 3.38%
Jun 30, 2025 2.35%
Mar 31, 2025 2.13%
Dec 31, 2024 5.33%
Sep 30, 2024 6.12%
Jun 30, 2024 4.58%
Mar 31, 2024 4.70%
Dec 31, 2023 0.79%
Sep 30, 2023 0.93%
Jun 30, 2023 0.54%
Mar 31, 2023 0.10%
Dec 31, 2022 0.88%
Sep 30, 2022 -1.03%
Jun 30, 2022 1.58%
Mar 31, 2022 1.12%
Dec 31, 2021 1.07%
Sep 30, 2021 2.57%
Jun 30, 2021 1.12%
Mar 31, 2021 0.69%
Dec 31, 2020 0.34%
Sep 30, 2020 -1.83%
Jun 30, 2020 -1.89%
Mar 31, 2020 -0.53%
Dec 31, 2019 0.06%
Sep 30, 2019 1.00%
Jun 30, 2019 0.98%
Mar 31, 2019 0.80%
Dec 31, 2018 -0.25%
Sep 30, 2018 1.18%
Jun 30, 2018 0.47%
Mar 31, 2018 0.35%
Dec 31, 2017 1.92%
Sep 30, 2017 -0.71%
Jun 30, 2017 0.86%
Mar 31, 2017 0.81%
Dec 31, 2016 2.28%
Sep 30, 2016 7.66%
Jun 30, 2016 6.76%
Mar 31, 2016 6.33%
Dec 31, 2015 3.33%
Sep 30, 2015 1.55%
Jun 30, 2015 1.87%
Mar 31, 2015 3.55%
Dec 31, 2014 5.70%
Sep 30, 2014 2.85%
Jun 30, 2014 3.85%
Mar 31, 2014 4.20%
Dec 31, 2013 5.50%
Sep 30, 2013 9.10%
Jun 30, 2013 8.14%
Mar 31, 2013 10.21%
Dec 31, 2012 9.33%
Sep 30, 2012 9.08%
Jun 30, 2012 8.91%
Mar 31, 2012 5.77%
Dec 31, 2011 5.83%
Sep 30, 2011 6.20%